1. Bousfiha A., Jeddane L., Picard C., Al-Herz W. et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J. Clin. Immunol. 2020;40(1):66-81. https://doi.org/10.1007/s10875-020-00758-x
2. Seidel M.G., Kindle G., Gathmann B., Quinti I. et al. The European society for immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J. Allergy Clin. Immunol. Pract. 2019;7(6):1763-70. https://doi.org/10.1016/j.jaip.2019.02.004
3. Кузьменко Н.Б., Щербина А.Ю. Классификация первичных иммунодефицитов как отражение современных представлений об их патогенезе и терапевтических подходах. Российский журнал детской гематологии и онкологии. 2017;4(3): 51-7. https://doi.org/10.17650/2311-1267-2017-4-3-51-57
4. Gupta A. Primary immunodeficiency disorders: where do we stand? Indian J. Pediatr. 2019;86 (10):873-4. https://doi.org/10.1007/s12098-01903031-1
5. Васильева М.М., Сай И.А. Первичные иммунодефициты с преимущественным нарушением синтеза антител. Здравоохранение Дальнего Востока. 2021;4:24-32. https://doi.org/10.33454/1728-1261-2021-4-24-32
6. Ягудина Л.А., Хакимова Д.М. Общая вариабельная иммунная недостаточность в клинической практике. Казанский медицинский журнал. 2015;96(2):249-52. https://doi.org/10.17750/KMJ2015-249
7. Swain S., Selmi C., Gershwin M.E., Teuber S.S. The clinical implications of selective IgA deficiency. J. Transl. Autoimmun. 2019;2:10025. https://doi.org/10.1016/j.jtaut.2019.100025
8. Москалец О.В. Случай селективного дефицита иммуноглобулина А, ассоциированного с аутоиммунным гастритом. Альманах клинической медицины. 2016;44(6):790-5. https://doi.org/10.18786/2072-0505-2016-44-6-790-795
9. Чучалин А.Г. Болезни, ассоциированные с иммуноглобулином G. Пульмонология. 2017;27(3):311-19. https://doi.org/10.18093/0869-0189-2017-27-3-311-319
10. Parker A.R., Shold M., Ramsden D.B., Ocejo-Vinyals J.G. et.al. The clinical utility of measuring IgG subclass immunoglobulins during immunological investigation for suspected primary antibody deficiencies. Lab. Medicine. 2017;48(4):314-25. https://doi.org/10.1093/labmed/lmx058
11. Barton J., Barton C., Bertoli L. Duration of frequent or severe respiratory tract infectionin adults before diagnosis of IgG subclass deficiency. PLoS One. 2019;14(5):e0216940. https://doi.org/10.1371/journal pone.026940
12. Lee S-H., Ban G-Y., Kim S-C., Chung C-G. et al. Association between primary immunodeficiency and asthma exacerbationin adult asthmatics. Korean J. Intern. Med. 2020;35(2):449-46. https://doi.org/10.3904/kjm.2018.413
13. Kim J-H., Jang J-H., Lee S-Y., Yang E-M., Jang S.H. et al. Specific antibody deficiency in adult patients with IgG or IgG subclass deficiency. Allergy Asthma Immunol. Res. 2021;13(2):271-83. https://doi.org/10.4168/aaar.2021.13.2.271
14. Shin J.J., Liauw D., Siddiqui S., Lee J. et al. Immunological and clinical phenotyping in primary antibody deficiencies: a growing disease spectrum. J. Clin. Immunol. 2020;40(4):592-601. https://doi.org/10.1007/s10875-020-00773-y
15. Barton J.C., Barton J.C., Bertoli L.F., Acton R.T. Characterization of adult patients with IgG subclassdeficiency and subnormal IgG2. PLoS One. 2020;15(10):e0240522. https://doi.org/10.1371/journal.pone.0240552
16. Modell V., Orange J.S., Quinn J., Modell F. Global report of primary immunodeficiencies: 2018 update from the Jeffrey Model Centers Network on disease classification, regional trends, treatment modalities and physician reported outcomes. Immunol. Res. 2018;66(3):367-80. https://doi.org/10.1017/s12026-018-8996-5
17. Donq J., Liaq H., Wen D., Wanq J. Adult common immunodeficiency. Am. J. Med. Sci. 2016;351(3):239-43. https://doi.org/10.1016/j.amjms.2015.12.010
18. Abrahamian J., Agrawal S., Gupta S. Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy. Clin. Exp. Immunol. 2010;159(3):344-50. https://doi.org/10.1111/j.1365-2249.2009.04062-x
19. Smith B.M., Buddle I.K., deVries E., Berge I.J.M. et al. Immunoglobulin replacementtherapy versus antibiotic prophylaxis as treatment for incomplete primary antibody deficiency. J. Clin. Immunol. 2021;41(2):382-92. https://doi.org/10.1007/s108575-020-00841-3
Послать статью по эл. почте 